Abstract Background: Chikungunya arthritis comprises overlapping pain-dominant, periarticular, inflammatory, and rheumatoid arthritis (RA)-like clinical phenotypes. Symptom duration alone does not capture this heterogeneity. Scope: This narrative review evaluates virological assays, antiviral and autoimmune serology, inflammatory mediators, imaging, and clinical outcomes. Human observations are distinguished from animal and cell-based mechanisms. Findings: Most biomarker evidence is exploratory.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Wenxia
Contact Wenxia, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack